21900-34-5

Basic information

• Product Name: 3-bromo-4-chlorobenzoyl chloride
• Synonyms: 3-bromo-4-chlorobenzoyl chloride
• CAS NO: 21900-34-5
• Molecular Formula: C₇H₃BrCl₂O
• Molecular Weight: 253.90812
• Mol File: 21900-34-5.mol
• Article Data: 12

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-bromo-4-chlorobenzoyl chloride(CAS DataBase Reference)
• NIST Chemistry Reference: 3-bromo-4-chlorobenzoyl chloride(21900-34-5)
• EPA Substance Registry System: 3-bromo-4-chlorobenzoyl chloride(21900-34-5)

Safety Data

• Hazardous Substances Data: 21900-34-5(Hazardous Substances Data)

Upstream product

• 42860-10-6 3-bromo-4-chlorobenzoic acid 
• 2840-28-0 3-amino-4-chloro-benzoic acid 
• 57310-39-1 2-bromo-1-chloro-4-methylbenzene 
• 89-62-3 4-methyl-2-nitroaniline 

Downstream Products

• 57487-46-4 C₂₂H₁₅BrCl₃N₅O 
• 913067-93-3 3-bromo-4-chloro-N-(3-(trifluoromethyl)phenyl)benzamide 
• 791137-22-9 3-bromo-4-chlorobenzamide 
• 938163-32-7 C₉H₅BrClNO 
• 938163-38-3 3-(3-bromo-4-chlorophenyl)-3-oxopropanamide 
• 938163-43-0 2-bromo-3-(3-bromo-4-chlorophenyl)-3-oxopropanamide 
• 834895-52-2 3-bromo-4-pyrrolidinobenzophenone 
• 834895-57-7 1-(3-bromo-4-pyrrolidinophenyl)-1-phenylprop-2-yn-1-ol 
• 834895-43-1 3-(3-bromo-4-pyrrolidinophenyl)-3-phenyl-3H-naphtho[2,1-b]pyran 
• 1068709-27-2 (3-bromo-4-chlorophenyl)(3-(3,5-dibromo-4-(4-methoxybenzyloxy)phenyl)-4,5-dihydro-1H-pyrazol-1-yl)methanone 
• 1025772-28-4 (R)-3-bromo-4-chloro-N-(1-phenylethyl)benzamide 
• 1070892-06-6 3-bromo-4-chloro-N-(2-methoxy-phenyl)-benzamide 
• 1070892-12-4 3-bromo-4-chloro-N-(2-hydroxy-phenyl)-N-methyl-benzamide 
• 1070892-27-1 3-bromo-4-chloro-N-(2-hydroxy-6-methyl-phenyl)-benzamide 

Relevant articles and documents

BENZAZOLE DERIVATIVE HAVING HETEROARYL GROUP AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME

Disclosed is a benzazole derivative having a heteroaryl group, wherein the benzazole derivative having the heteroaryl group is represented by Chemical Formula 1. Also disclosed is an organic electroluminescence device including an organic layer containing

COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS

Compounds, methods of use, and processes for making inhibitors of complement Factor D are provided comprising Formula I, I" and I'" or a pharmaceutically acceptable salt or composition thereof. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade. The inhibitors of Factor D described herein reduces the excessive activation of complement.

Dual Pharmacophores - PDE4-Muscarinic Antagonistics

The present invention is directed to novel compounds of Formula (I), pharmaceutical compositions and their use in therapy, for example as inhibitors of phosphodiesterase type IV (PDE4) and as antagonists of muscarinic acetylcholine receptors (mAChRs), in the treatment of/and or prophylaxis of respiratory diseases, including antiinflammatory and/or allergic diseases such as chronic obstructive pulmonary disease (COPD), asthma, rhinitis (e.g. allergic rhinitis), atopic dermatitis or psoriasis.